HemOnc Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents

Fox Chase Cancer Center appoints assistant professor of thoracic surgery

Array, Merck to collaborate on trial of binimetinib, pembrolizumab for metastatic colorectal cancer

National repository offers ‘endless’ potential for hemophilia research

Counseling visit impacts patients’ decision to undergo lung cancer screening

University of Michigan prostate cancer risk clinic may make ‘dramatic impact’ on disease burden, mortality

Light-scattering tool may improve early identification of pancreatic cancer

Loyola Medicine appoints vice chair in radiation oncology department

Children’s Hospital of Philadelphia appoints section chief

Conquer Cancer Foundation of ASCO to present awards

Federal budget proposal would deal ‘devastating blow’ to medical research

Failed confirmatory trial raises questions about atezolizumab for advanced urothelial cancer

Society recognizes St. Jude Children’s Research Hospital president, CEO

Abemaciclib regimen extends PFS among certain women with advanced breast cancer

Winship Cancer Institute joins elite status of NCI–designated comprehensive cancer centers

Dana-Farber Cancer Institute appoints gastrointestinal cancer center director

Addition of ublituximab to ibrutinib improves response in high-risk CLL

Patient education pivotal when recommending palliative care

Cover Story

Malnutrition ‘almost epidemic’ among patients with advanced cancer

Editorial

‘Covfefe’ — the real meaning

Derek Raghavan, MD, PhD

FDA News

FDA issues warnings about fraudulent cancer treatments

FDA clears marketing of scalp-cooling system to reduce chemotherapy-associated hair loss

FDA grants accelerated approval to brigatinib for ALK–positive NSCLC

FDA grants Lynparza priority review for maintenance treatment of ovarian cancer

FDA clears marketing of scalp-cooling system to reduce chemotherapy-associated hair loss

FDA advisory committee expresses support for three therapies

In the Journals Plus

Homologous recombination deficiency analysis predicts PARP inhibitor benefit for ovarian cancer

Hematopoietic cell transplant survivors face greater late morbidity, mortality

Younger age associated with genetic alterations in lung adenocarcinoma

Few women with early-stage breast cancer seek second opinion

F. nucleatum associated with poor survival in esophageal cancer

Rivaroxaban noninferior to fondaparinux for superficial vein thrombosis

Pembrolizumab exhibits antitumor activity in recurrent HNSCC

Selumetinib appears beneficial for children with inoperable plexiform neurofibromas

Young patients experience poor social functioning years after cancer diagnosis

Updated ASTRO guideline expands pool of accelerated partial breast irradiation candidates

Older patients with NSCLC experience high treatment burden

Inflammatory bowel disease a risk factor for VTE in pregnant women

Incidence, prevalence of neuroendocrine tumors on the rise

Longer-interval zoledronic acid dosing noninferior to standard dosing for bone metastases

Minimal residual disease negativity associated with longer survival in ALL

Men with HIV, nonmelanoma skin cancer at greater risk for Kaposi’s sarcoma

Complete response at 30 months serves as surrogate endpoint in follicular lymphoma

Despite requests, many women with breast cancer do not receive genetic tests

Apixaban lowers risk for intracranial hemorrhages in patients with atrial fibrillation

Complete surgical metastasectomy improves survival in late-stage renal cell carcinoma

Biosimilar may provide affordable, effective trastuzumab alternative

Active surveillance of prostate cancer associated with favorable outcomes in younger men

Addition of cetuximab improves outcomes in KRAS-variant HNSCC

Addition of bortezomib to lenalidomide, dexamethasone improves myeloma survival

Meeting News

Affordable Care Act increases screening, early diagnosis of certain cancers

Low testosterone levels prevalent among testicular cancer survivors

Alvimopan may shorten hospital stays after surgery for testicular cancer

Psychological intervention reduces cancer survivors’ fear of recurrence

Single-dose radiotherapy should be standard for metastatic spinal canal compression

New molecules may offer next-generation treatment in prostate cancer

HPV vaccination confers high degree of protection against oral infections, despite underuse

Exercise, healthy diet extend colon cancer survival

E-cigarettes may increase bladder cancer risk

Pharmacology Consult

Effective pharmacological management of depression ‘imperative’ for patients with cancer

Jai N. Patel, PharmD, BCOP

Point/Counter

Do the benefits of a feeding tube outweigh the risks for a malnourished patient with cancer treated with curative intent?

Advertisement
Advertisement